Genmab A/S Share Price Nasdaq
Stocks
GMAB
US3723032062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
Pre-market 05:33:18 pm | |||
| 29.17 USD | +1.11% |
|
28.76 | -1.42% |
| 11:38am | One hundred dollars and a market beating |  |
| 10:20am | Nordic stocks in North America, Ericsson fell 0.7% | FW |
| Market Cap | 12TCr 1.78TCr 1.56TCr 1.45TCr 1.34TCr 2.51TCr 1,72200Cr 2.55TCr 17TCr 6.78TCr 84TCr 6.68TCr 6.53TCr 2,91400Cr | P/E 2026 * |
24.9x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 14TCr 2.07TCr 1.82TCr 1.69TCr 1.56TCr 2.92TCr 2,00800Cr 2.97TCr 20TCr 7.9TCr 98TCr 7.78TCr 7.61TCr 3,39700Cr | EV / Sales 2026 * |
4.83x | EV / Sales 2027 * | 3.88x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab A/S
| 1 day | -0.96% | ||
| 1 week | +0.66% | ||
| Current month | +6.19% | ||
| 1 month | +12.45% | ||
| 3 months | +8.12% | ||
| 6 months | -13.90% | ||
| Current year | -5.29% |
| 1 week | 27.86 |  | 29.32 |
| 1 month | 25.34 | | 29.8 |
| Current year | 23.62 | | 35.43 |
| 1 year | 21 | | 35.43 |
| 3 years | 17.24 | | 42.72 |
| 5 years | 17.24 | | 49.07 |
| 10 years | 12.1 | | 49.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Deirdre Connelly
CHM | Chairman | 65 | 26/03/2020 |
| Director/Board Member | 75 | 01/11/2003 | |
Rolf K. Hoffmann
BRD | Director/Board Member | 66 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | +0.66% | - | - | 1.78TCr | |
| +1.23% | +0.35% | +51.62% | +87.98% | 5.59TCr | |
| +2.46% | +8.62% | +65.34% | +70.56% | 5.67TCr | |
| +0.25% | +0.55% | -19.67% | -15.22% | 2.33TCr | |
| +0.72% | -0.05% | +3.84% | +409.54% | 2.33TCr | |
| -0.36% | +5.73% | +30.99% | -3.58% | 2.05TCr | |
| -1.44% | +5.67% | +32.54% | +544.11% | 1.59TCr | |
| -2.54% | -8.73% | +164.11% | +289.45% | 1.46TCr | |
| +1.22% | -0.05% | +22.58% | +182.63% | 1.4TCr | |
| -2.16% | +21.58% | +445.10% | +140.52% | 1.22TCr | |
| Average | -0.16% | +3.58% | +88.49% | +189.55% | 2.63TCr | |
| Weighted average by Cap. | +0.54% | +4.31% | +65.70% | +148.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.82TCr 429.66Cr 377.88Cr 351.05Cr 322.87Cr 605.49Cr 42TCr 616.34Cr 4.2TCr 1.64TCr 20TCr 1.61TCr 1.58TCr 70TCr | 3.32TCr 504.66Cr 443.85Cr 412.33Cr 379.23Cr 711.19Cr 49TCr 723.93Cr 4.93TCr 1.92TCr 24TCr 1.89TCr 1.85TCr 83TCr |
| Net income | 481.52Cr 73Cr 64Cr 60Cr 55Cr 103.22Cr 7.09TCr 105.07Cr 715.61Cr 279.13Cr 3.46TCr 274.97Cr 269.02Cr 12TCr | 705.4Cr 107.3Cr 94Cr 88Cr 81Cr 151.21Cr 10TCr 153.92Cr 1.05TCr 408.91Cr 5.07TCr 402.82Cr 394.11Cr 18TCr |
| Net Debt | 1.94TCr 295.12Cr 259.56Cr 241.13Cr 221.77Cr 415.89Cr 29TCr 423.35Cr 2.88TCr 1.12TCr 14TCr 1.11TCr 1.08TCr 48TCr | 1.18TCr 179.77Cr 158.11Cr 146.88Cr 135.09Cr 253.34Cr 17TCr 257.88Cr 1.76TCr 685.09Cr 8.49TCr 674.9Cr 660.3Cr 29TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $29.17 | +1.11% | 11,35,422 |
| 22/26/22 | $28.85 | +1.71% | 18,52,893 |
| 21/26/21 | $28.37 | +1.63% | 8,71,699 |
| 20/26/20 | $27.91 | -2.82% | 12,45,539 |
| 17/26/17 | $28.72 | -0.90% | 26,29,330 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
